Effects physostigmine spatial attention patients progressive supranuclear palsy patients progressive supranuclear palsy control subjects task visuopatial attention Targets cues side opposite side subjects targets difference reaction times targets attentional movement patients performance controls certain neuropsychological tests attentional ability correlations progressive supranuclear palsy Physostigmine treatment patients speeding responses cued targets function duration disease studies defects cognition attention patients progressive supranuclear palsy demonstrate physostigmine abnormal visual attentional performance 